MANTLE CELL LYMPHOMA

Clinical trials for MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 48 Not yet recruiting 6 Not yet finished but already full! 24 Completed 12 Terminated 1

Early trial halted for new lymphoma pill

Disease control Terminated

This early-stage study tested a new oral drug called TQB3909 in adults whose mantle cell lymphoma had returned or stopped responding to other treatments. The main goals were to find a safe dose for future testing and to closely monitor for any side effects. The trial was terminat…

Matched conditions: MANTLE CELL LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

MANTLE CELL LYMPHOMA

Get alerted when new MANTLE CELL LYMPHOMA trials appear

Early trial halted for new lymphoma pill